首页> The Journal of Antimicrobial Chemotherapy> Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.

导出原文传递

翻译打印收藏纠错

第一作者： Lopez-Cortes LF

作者： Lopez-Cortes LF ^[1] ; Ruiz-Valderas R ; Ruiz-Morales J ; Leon E ; de-Campos AV ; Marin-Niebla A ; Marquez-Solero M ; Lozano F ; Valiente R

作者单位： Infectious Diseases Service, Hospitales Universitarios, Virgen del Rocio, Seville, Spain. lflopez@telefonica.net ^[1]

关键词 Adult Anti-HIV Agents Antibiotics Antitubercular Benzoxazines Drug Administration Schedule 成年人抗HIV药抗生素类抗结核用药计划表药物相互作用 HIV感染分支杆菌结核

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Antimicrobial Chemotherapy

2006年58卷5期

1017-1023页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

The Journal of Antimicrobial Chemotherapy

2006年58卷5期

1017-1023页

检索历史清除

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.

The Journal of Antimicrobial Chemotherapy

相似文献

同项目论文

The Journal of Antimicrobial Chemotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.

The Journal of Antimicrobial Chemotherapy

相似文献

同项目论文

The Journal of Antimicrobial Chemotherapy

相关期刊

检索历史清除